Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.864 USD | -5.44% | +44.98% | +21.32% |
04-26 | VolitionRx Limited Announces Board Changes | CI |
04-23 | VolitionRx Limited Launches In-Clinic in U.S. and Europe Through Antech | CI |
Sales 2024 * | 3.63M 4.96M | Sales 2025 * | 16.48M 22.52M | Capitalization | 75.02M 103M |
---|---|---|---|---|---|
Net income 2024 * | -36M -49.2M | Net income 2025 * | -32M -43.73M | EV / Sales 2024 * | 18.2 x |
Net cash position 2024 * | 8.9M 12.16M | Net Debt 2025 * | 18.4M 25.15M | EV / Sales 2025 * | 5.67 x |
P/E ratio 2024 * |
-2.25
x | P/E ratio 2025 * |
-2.83
x | Employees | 110 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.08% |
Latest transcript on VolitionRx Limited
1 day | -5.44% | ||
1 week | +44.98% | ||
Current month | +14.91% | ||
1 month | +12.38% | ||
3 months | -10.32% | ||
6 months | +8.60% | ||
Current year | +21.32% |
Managers | Title | Age | Since |
---|---|---|---|
Cameron Reynolds
CEO | Chief Executive Officer | 53 | 11-10-05 |
Terig Hughes
DFI | Director of Finance/CFO | 54 | 21-01-31 |
Gaetan Michel
COO | Chief Operating Officer | 51 | 21-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Cameron Reynolds
CEO | Chief Executive Officer | 53 | 11-10-05 |
Martin Faulkes
CHM | Chairman | 80 | 11-10-05 |
Guy Innes
BRD | Director/Board Member | 67 | 11-10-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 0.8699 | -4.79% | 81 286 |
24-04-26 | 0.9137 | +2.65% | 210,159 |
24-04-25 | 0.8902 | +11.27% | 489,819 |
24-04-24 | 0.8 | -5.88% | 354,848 |
24-04-23 | 0.85 | +41.67% | 3,440,054 |
Delayed Quote Nyse, April 29, 2024 at 03:20 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.32% | 75.02M | |
-20.40% | 10.82B | |
+47.79% | 3.25B | |
-33.09% | 2.11B | |
-14.15% | 2.08B | |
-25.99% | 1.48B | |
+19.62% | 1.02B | |
-2.62% | 733M | |
-31.29% | 391M | |
-43.68% | 383M |
- Stock Market
- Equities
- VNRX Stock